EX-99.1 10 hcp-20151231ex991dfb55f.htm EX-99.1

EXHIBIT 99.1

C onsolidated Financial Statements HCR ManorCare, Inc. For the years ended December 31, 2015, 2014 and 2013 With Report of Independent Auditors

Report of Independent Auditors

The Board of Directors and Shareholders of HCR ManorCare, Inc.

We have audited the accompanying consolidated financial statements of HCR ManorCare, Inc., which comprise the consolidated balance sheets as of December 31, 2015 and 2014, and the related consolidated statements of operations, comprehensive loss, cash flows and equity for each of the three years in the period ended December 31, 2015, and the related notes to the consolidated financial statements.

Management’s Responsibility for the Financial Statements

Management is responsible for the preparation and fair presentation of these consolidated financial statements in conformity with U.S. generally accepted accounting principles; this includes the design, implementation, and maintenance of internal control relevant to the preparation and fair presentation of consolidated financial statements that are free of material misstatement, whether due to fraud or error.

Auditor’s Responsibility

O ur responsibility is to express an opinion on these consolidated financial statements based on our audits. We conducted our audits in accordance with auditing standards generally accepted in the United States and in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement.

An audit involves performing procedures to obtain audit evidence about the amounts and disclosures in the financial statements. The procedures selected depend on the auditor’s judgment, including the assessment of the risks of material misstatement of the financial statements, whether due to fraud or error. In making those risk assessments, the auditor considers internal control relevant to the entity’s preparation and fair presentation of the financial statements in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the entity’s internal control. Accordingly, we express no such opinion. An audit also includes evaluating the appropriateness of accounting policies used and the reasonableness of significant accounting estimates made by management, as well as evaluating the overall presentation of the financial statements.

We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion.

Opinion

In our opinion, the financial statements referred to above present fairly, in all material respects, the consolidated financial position of HCR ManorCare, Inc. at December 31, 2015 and 2014, and the consolidated results of its operations and its cash flows for each of the three years in the period ended December 31, 2015 in conformity with U.S. generally accepted accounting principles.

Emphasis of Matter

As discussed in Note 3 to the consolidated financial statements, the Company changed its method for reporting discontinued operations and disclosures of disposals of components of an entity effective January 1, 2015. Our opinion is not modified with respect to this matter.

/s/ Ernst & Young LLP

Toledo, Ohio

January 29, 2016

1

HCR M anor C are, Inc.

Consolidated Balance Sheets

|  | December 31, |
|  | 2015 |  | 2014 |
|  | (In thousands, except share data) |
Assets |  |  |  |  |  |  |
Current assets: |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 124,982 |  | $ | 127,850 |
Restricted cash and cash equivalents |  |  | 18,697 |  |  | 12,613 |
Receivables, less allowance for doubtful accounts of $100,261 and $94,309, respectively |  |  | 453,386 |  |  | 458,957 |
Prepaid expenses and other assets |  |  | 16,109 |  |  | 14,555 |
Income taxes receivable |  |  | 2,196 |  |  | 12,811 |
Assets held for sale, less allowance for losses |  |  | 134,747 |  |  | 9,501 |
Total current assets |  |  | 750,117 |  |  | 636,287 |
Net property and equipment |  |  | 2,628,534 |  |  | 2,934,441 |
Deferred income taxes |  |  | 982,542 |  |  | 985,224 |
Goodwill |  |  | 2,604,060 |  |  | 2,736,519 |
Intangible assets |  |  | 300,923 |  |  | 303,247 |
Other assets |  |  | 85,655 |  |  | 88,324 |
Total assets |  | $ | 7,351,831 |  | $ | 7,684,042 |
Liabilities and Equity |  |  |  |  |  |  |
Current liabilities: |  |  |  |  |  |  |
Accounts payable |  | $ | 108,233 |  | $ | 106,270 |
Employee compensation and benefits |  |  | 142,273 |  |  | 148,307 |
Accrued provider assessments |  |  | 29,754 |  |  | 16,467 |
Accrued insurance liabilities |  |  | 137,447 |  |  | 139,906 |
Other accrued liabilities |  |  | 88,557 |  |  | 71,015 |
Long-term debt and financing obligation due within one year |  |  | 130,721 |  |  | 180,093 |
Total current liabilities |  |  | 636,985 |  |  | 662,058 |
Long-term debt and financing obligation |  |  | 5,705,648 |  |  | 5,928,222 |
Other liabilities |  |  | 476,725 |  |  | 450,735 |
Redeemable preferred stock - series A, $0.01 par value, redemption value $1,025 per share; 2,000 shares authorized, issued and outstanding |  |  | 2,050 |  |  | 2,050 |
Equity: |  |  |  |  |  |  |
HCR ManorCare, Inc. shareholders' equity: |  |  |  |  |  |  |
Preferred stock, $0.01 par value, 49,998,000 shares authorized; none issued |  |  | - |  |  | - |
Common stock, $0.01 par value, 55,000,000 shares authorized; 46,830,718 and 45,221,535 shares issued, respectively |  |  | 468 |  |  | 452 |
Capital in excess of par value |  |  | 3,036,276 |  |  | 3,037,783 |
Retained deficit |  |  | (2,510,445) |  |  | (2,400,298) |
Accumulated other comprehensive loss |  |  | (975) |  |  | (2,828) |
Total HCR ManorCare, Inc. shareholders' equity |  |  | 525,324 |  |  | 635,109 |
Noncontrolling interest |  |  | 5,099 |  |  | 5,868 |
Total equity |  |  | 530,423 |  |  | 640,977 |
Total liabilities and equity |  | $ | 7,351,831 |  | $ | 7,684,042 |

See accompanying notes.

2

HCR M anor C are, Inc.

Consolidated Statemen ts of Operations

|  | Year ended December 31, |
|  | 2015 |  | 2014 |  | 2013 |
|  | (In thousands) |
Revenues |  | $ | 4,079,575 |  | $ | 4,145,520 |  | $ | 4,117,000 |
Expenses: |  |  |  |  |  |  |  |  |  |
Operating |  |  | 3,410,538 |  |  | 3,423,430 |  |  | 3,342,920 |
General and administrative |  |  | 137,992 |  |  | 149,481 |  |  | 151,238 |
Depreciation and amortization |  |  | 137,437 |  |  | 142,867 |  |  | 142,569 |
Asset impairment |  |  | - |  |  | 203,108 |  |  | - |
|  |  | 3,685,967 |  |  | 3,918,886 |  |  | 3,636,727 |
Income before other (expenses) income and income taxes |  |  | 393,608 |  |  | 226,634 |  |  | 480,273 |
Other (expenses) income: |  |  |  |  |  |  |  |  |  |
Interest expense |  |  | (457,557) |  |  | (406,854) |  |  | (413,909) |
Loss on disposal of assets |  |  | (46,720) |  |  | (1,424) |  |  | (1) |
Equity in earnings of affiliated company |  |  | 10,567 |  |  | 3,144 |  |  | 5,374 |
Interest income and other |  |  | 386 |  |  | 3,978 |  |  | 1,160 |
Total other expenses, net |  |  | (493,324) |  |  | (401,156) |  |  | (407,376) |
(Loss) income from continuing operations before income taxes |  |  | (99,716) |  |  | (174,522) |  |  | 72,897 |
Income taxes |  |  | 5,586 |  |  | 210,404 |  |  | 422,105 |
Loss from continuing operations |  |  | (105,302) |  |  | (384,926) |  |  | (349,208) |
Loss from discontinued operations, net of taxes |  |  | (5,540) |  |  | (9,001) |  |  | (9,484) |
Net loss |  |  | (110,842) |  |  | (393,927) |  |  | (358,692) |
Less net (loss) income attributable to noncontrolling interest |  |  | (895) |  |  | (375) |  |  | 1,129 |
Net loss attributable to controlling interest |  | $ | (109,947) |  | $ | (393,552) |  | $ | (359,821) |

See accompanying notes.

3

HCR ManorCare, Inc.

Consolidated St atements of Comprehensive Loss

|  | Year ended December 31, |
|  | 2015 |  | 2013 |  | 2013 |
|  | (In thousands) |
Net loss |  | $ | (110,842) |  | $ | (393,927) |  | $ | (358,692) |
Other comprehensive income (loss) from |  |  |  |  |  |  |  |  |  |
defined benefit pension plans, net of tax |  |  | 1,853 |  |  | (1,874) |  |  | 963 |
Comprehensive loss |  |  | (108,989) |  |  | (395,801) |  |  | (357,729) |
Less comprehensive (loss) income attributable to noncontrolling interest |  |  | (895) |  |  | (375) |  |  | 1,129 |
Comprehensive loss attributable to controlling interest |  | $ | (108,094) |  | $ | (395,426) |  | $ | (358,858) |

See accompanying notes.

4

HCR ManorCare, Inc.

Consolidated Statements of Cash Flows

|  | Year ended December 31, |
|  | 2015 |  | 2014 |  | 2013 |
|  | (In thousands) |
Operating Activities |  |  |  |  |  |  |  |  |  |
Net loss |  | $ | (110,842) |  | $ | (393,927) |  | $ | (358,692) |
Adjustments to reconcile net loss to net cash provided by operating activities: |  |  |  |  |  |  |  |  |  |
Depreciation and amortization |  |  | 137,437 |  |  | 143,992 |  |  | 145,964 |
Deferred finance fee amortization |  |  | 3,401 |  |  | 3,507 |  |  | 3,484 |
Pension amortization |  |  | 262 |  |  | 1,241 |  |  | 145 |
Asset impairment |  |  | - |  |  | 203,108 |  |  | - |
Unrealized investment loss (gain) |  |  | 2,208 |  |  | (1,554) |  |  | 3,997 |
Restricted stock and stock option compensation |  |  | - |  |  | 120 |  |  | 580 |
Provision for bad debts |  |  | 83,833 |  |  | 76,027 |  |  | 72,155 |
Provision for deferred income taxes |  |  | 1,538 |  |  | 212,047 |  |  | 430,321 |
Net loss (gain) on sale of assets, securities, and other |  |  | 40,615 |  |  | (4,904) |  |  | (11,709) |
Equity in earnings of affiliated company |  |  | (10,567) |  |  | (3,144) |  |  | (5,374) |
Changes in assets and liabilities: |  |  |  |  |  |  |  |  |  |
Receivables |  |  | (78,262) |  |  | (31,892) |  |  | (35,947) |
Prepaid expenses and other assets |  |  | 19,414 |  |  | 103,895 |  |  | (5,277) |
Liabilities |  |  | 52,945 |  |  | (83,680) |  |  | (7,065) |
Total adjustments |  |  | 252,824 |  |  | 618,763 |  |  | 591,274 |
Net cash provided by operating activities |  |  | 141,982 |  |  | 224,836 |  |  | 232,582 |
Investing Activities |  |  |  |  |  |  |  |  |  |
Investment in property and equipment |  |  | (81,044) |  |  | (94,849) |  |  | (95,554) |
Investment in systems development |  |  | (1,555) |  |  | (384) |  |  | (1,528) |
Proceeds from sale of assets |  |  | 221,623 |  |  | 13,969 |  |  | 12,137 |
Purchase of securities |  |  | (17,277) |  |  | (23,806) |  |  | (3,187) |
Proceeds from sale of securities |  |  | 12,204 |  |  | 28,078 |  |  | - |
Distributions from affiliated company |  |  | - |  |  | - |  |  | 939 |
Purchase of noncontrolling interest |  |  | (2,309) |  |  | - |  |  | - |
Net change in restricted cash and cash equivalents |  |  | (3,545) |  |  | (7,346) |  |  | (7,074) |
Net cash provided by (used in) investing activities |  |  | 128,097 |  |  | (84,338) |  |  | (94,267) |
Financing Activities |  |  |  |  |  |  |  |  |  |
Payment of debt and financing obligation |  |  | (271,946) |  |  | (153,019) |  |  | (116,135) |
Payment of financing costs |  |  | (1,824) |  |  | (64) |  |  | - |
Preferred dividends paid |  |  | (200) |  |  | (200) |  |  | (200) |
Contributions from noncontrolling interest |  |  | 1,536 |  |  | - |  |  | - |
Distributions to noncontrolling interest |  |  | (513) |  |  | (1,162) |  |  | (665) |
Net cash used in financing activities |  |  | (272,947) |  |  | (154,445) |  |  | (117,000) |
Net (decrease) increase in cash and cash equivalents |  |  | (2,868) |  |  | (13,947) |  |  | 21,315 |
Cash and cash equivalents at beginning of year |  |  | 127,850 |  |  | 141,797 |  |  | 120,482 |
Cash and cash equivalents at end of year |  | $ | 124,982 |  | $ | 127,850 |  | $ | 141,797 |

See accompanying notes.

5

HCR ManorCare, Inc.

Consolidated Statements of Equity

|  | Shareholders' Equity |  |  |  |  |  |  |
|  |  |  |  |  |  |  |  |  |  |  |  |  | Accum. |  |  |  |  |  |  |
|  |  |  |  |  |  | Capital in |  |  |  | Other |  | Non- |  |  |  |
|  | Common |  | Excess of |  | Retained |  | Comp. |  | controlling |  | Total |
|  | Shares |  | Amounts |  | Par Value |  | (Deficit) |  | (Loss) |  | Interest |  | Equity |
|  | (In thousands) |
Balance at January 1, 2013 |  |  | 44,621 |  | $ | 446 |  | $ | 3,037,099 |  | $ | (1,646,525) |  | $ | (1,917) |  | $ | 6,941 |  | $ | 1,396,044 |
Stock-based compensation |  |  |  |  |  |  |  |  | 580 |  |  |  |  |  |  |  |  |  |  |  | 580 |
Forfeited non-vested shares |  |  | (15) |  |  | - |  |  |  |  |  |  |  |  |  |  |  |  |  |  | - |
Tax deficiency from stock transactions |  |  |  |  |  |  |  |  | (10) |  |  |  |  |  |  |  |  |  |  |  | (10) |
Distributions to noncontrolling interest |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (665) |  |  | (665) |
Preferred dividends |  |  |  |  |  |  |  |  |  |  |  | (200) |  |  |  |  |  |  |  |  | (200) |
Net (loss) income |  |  |  |  |  |  |  |  |  |  |  | (359,821) |  |  |  |  |  | 1,129 |  |  | (358,692) |
Other comprehensive income |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 963 |  |  |  |  |  | 963 |
Balance at December 31, 2013 |  |  | 44,606 |  |  | 446 |  |  | 3,037,669 |  |  | (2,006,546) |  |  | (954) |  |  | 7,405 |  |  | 1,038,020 |
Stock-based compensation |  |  |  |  |  |  |  |  | 120 |  |  |  |  |  |  |  |  |  |  |  | 120 |
Issuance of restricted stock |  |  | 255 |  |  | 2 |  |  | (2) |  |  |  |  |  |  |  |  |  |  |  | - |
Exchange of stock options for restricted stock |  |  | 374 |  |  | 4 |  |  | (4) |  |  |  |  |  |  |  |  |  |  |  | - |
Forfeited non-vested shares |  |  | (13) |  |  | - |  |  | - |  |  |  |  |  |  |  |  |  |  |  | - |
Distributions to noncontrolling interest |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (1,162) |  |  | (1,162) |
Preferred dividends |  |  |  |  |  |  |  |  |  |  |  | (200) |  |  |  |  |  |  |  |  | (200) |
Net loss |  |  |  |  |  |  |  |  |  |  |  | (393,552) |  |  |  |  |  | (375) |  |  | (393,927) |
Other comprehensive loss |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (1,874) |  |  |  |  |  | (1,874) |
Balance at December 31, 2014 |  |  | 45,222 |  | $ | 452 |  | $ | 3,037,783 |  | $ | (2,400,298) |  | $ | (2,828) |  | $ | 5,868 |  | $ | 640,977 |
Issuance of restricted stock |  |  | 1,640 |  |  | 16 |  |  | (16) |  |  |  |  |  |  |  |  |  |  |  | - |
Forfeited non-vested shares |  |  | (31) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | - |
Tax deficiency from stock transactions |  |  |  |  |  |  |  |  | (79) |  |  |  |  |  |  |  |  |  |  |  | (79) |
Purchase of noncontrolling interest |  |  |  |  |  |  |  |  | (1,412) |  |  |  |  |  |  |  |  | (897) |  |  | (2,309) |
Contributions from noncontrolling interest |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,536 |  |  | 1,536 |
Distributions to noncontrolling interest |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | (513) |  |  | (513) |
Preferred dividends |  |  |  |  |  |  |  |  |  |  |  | (200) |  |  |  |  |  |  |  |  | (200) |
Net loss |  |  |  |  |  |  |  |  |  |  |  | (109,947) |  |  |  |  |  | (895) |  |  | (110,842) |
Other comprehensive income |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 1,853 |  |  |  |  |  | 1,853 |
Balance at December 31, 2015 |  |  | 46,831 |  | $ | 468 |  | $ | 3,036,276 |  | $ | (2,510,445) |  | $ | (975) |  | $ | 5,099 |  | $ | 530,423 |

See accompanying notes.

6

HC R ManorCare, Inc.

Notes to Consolidated Financial Statements

1. General Information

Nature of Operations

HCR M anor C are, Inc. a nd subsidiaries (collectively, the Company) is a healthcare services provider that owns and operates skilled nursing and rehabilitation centers, assisted living facilities, memory care facilities, hospice and home care agencies, and outpatient rehabilitation clinics. As of December 31, 2015, t he long-term care business operates in 3 24 centers in 26 states, with 67% located in Florida, Illinois, Michigan, Ohio, and Pennsylvania. H ospice and home health services are based in 1 08 offices located in 2 3 states. Rehabilitation therapy services are provided in 49 outpatient therapy clinics as well as in a variety of other settings including skilled nursing centers, schools, and hospitals.

Principles of Consolidation and Basis of Presentation

The consolidated financial statements include the accounts of HCR ManorCare, Inc. and its wholly-own ed and majority-owned subsidiaries. Intercompany accounts and transactions with subsidiaries have been eliminated in consolidation. Certain prior year amounts have been reclassified to conform to the current year presentation.

The consolidated financial statements have been prepared in conformity with U.S. generally accepted accounting principles (U.S. GAAP) and include amounts based upon the estimates and judgments of management. Significant items subject to estimation include valuation of goodwill, other intangible and long-lived assets, allowance for doubtful accounts, deferred tax assets, self-insurance liabilities, income tax contingencies, and other contingencies. Actual results could differ from those estimates.

The Company uses the equity method to account for an investment in an entit y in which it has less than a majority interest but can exercise significant, but not a controlling, influence. The investment, a 50% ownership and voting interest in a pharmacy business, is classified on the accompanying balance sheets as other long-term assets in the amount of $18.4 million and $18.0 million at December 3 1, 20 1 5 and 20 1 4, respectively. T he investment, originally recorded at cost, is adjusted to recognize the Company’s share of the net earnings or losses of the affiliate as they occur. The Company’s purchases from the business amounted to $105.8 million in 2015, $104.2 million in 201 4, and $10 0.7 million in 201 3. The Company had a payable to the business of $11.3 million and $11.3 million at December 3 1, 201 5 and 201 4, respectively. The Company received dividends of $10.2 million in 2015, $3.1 million in 2014, and $5.0 million in 2013.

Unless otherwise indicated, all disclosures and amounts in the notes related to the statement of operations include only the Company’s continuing operations. See Note 11 for a discussion of discontinued operations and Note 3 for a discussion of 2015 divestitures that did not qualify for presentation as discontinued operations.

7

2. Significant Accounting Policies

Cash and Cash Equivalents

Investments with a n original maturity of three months or less when purchased are considered cash equivalents for purposes of the statements of cash flows.

R estricted cash and cash equivalents primarily include resident trust funds and funds held by the Company’s captive insurance subsidiary. Non-current r estricted cash of $4.1 million and $6.7 million at December 31, 201 5 and 2014, respectively, was held in a rabbi trust described below in the Marketable Securities policy. The current portion of restricted cash and cash equivalents is reported on a separate line item of the consolidated balance sheets and the non-current portion is included in other long-term assets.

Receivables and Revenues

Revenues are derived from services rendered to patients for long-term care, including skilled nursing and assisted living services, hospice and home health care, and rehabilitation therapy. Revenues are recognized as services are provided. Revenues are recorded net of provisions for discount arrangements with commercial payors and contractual allowances with third-party payors, primarily Medicare and Medicaid. Revenues realizable under third-party payor agreements are subject to change due to examinat ion and retroactive adjustment. Estimated third-party payor settlements are recorded in the period the related services are rendered. The methods of making such estimates are reviewed periodically, and differences between the net amounts accrued and subsequent settlements or estimates of expected settlements are reflected in the current period results of operations. The balance for third-party settlements was a net payable of $20.9 million and $5.5 million at December 31, 201 5 and 2014, respectively, which was included in other current liabilities.

Allowance for Doubtful Accounts

The Company evaluates the collectability of its accounts receivable based on cer tain factors, such as historical and current collection trends, and aging categories. The percentage that is applied to the receivable balances is based on the Company’s historical experience for each particular pay source. Accounts are written off when all reasonable internal and external collection efforts have been performed.

The activity in the allowance for doubtful accounts was as follows:

|  | 2015 |  | 2014 |  | 2013 |
|  | (In thousands) |
Balance at January 1 |  | $ | 94,309 |  | $ | 90,248 |  | $ | 90,459 |
Charged to costs and expenses |  |  | 83,833 |  |  | 76,027 |  |  | 72,155 |
Deductions |  |  | (77,881) |  |  | (71,966) |  |  | (72,366) |
Balance at December 31 |  | $ | 100,261 |  | $ | 94,309 |  | $ | 90,248 |

The deductions included uncollectible accounts written off net of recoveries.

Property and Equipment

Property and equipment are recorded at cost. Depreciation is provided by the straight-line method over the estimated useful lives of the assets, generally three to 10 years for equipment and furnishings and three to 40 years for buildings and improvements. Leasehold improvements are amortized over the shorter of the useful life or the contractual term of the lease. Direct incremental costs are capitalized for major development projects and are amortized over the lives of the related assets.

8

Sale-Leaseback Financing Obligation

The Company accounts for sale-leaseback transactions as financing arrangements when, as seller/lessee, it has continuing involvement with the property sold. The properties remain on the consolidated balance sheet s after the sale-leaseback and depreciat ion continues over the remaining useful lives. No gain is recognized, and proceeds received from the transaction are recorded as a financing obligation. The contractual lease payments are recorded in part as interest expense and in part as a payment of principal reducing the financing obligation. See Note 8 for discussion of the lease transactions and financing obligations.

Goodwill and Intangible Assets

Goodwill represents the excess of cost over the fair value of net assets of businesses acquired. Indefinite-lived intangible assets include trademarks, tradenames, and certificates of need, which a r e recorded based on fair value. The Company’s reporting units are consistent with its operating segments. Goodwill has been allocated to the Co mpany’s two reportable segments: long-term care and hospice and home health. Goodwill and indefinite-lived intangible assets are not amortized, but are reviewed at least annually on October 1 for impairment, or more frequently if events or circumstances arise which indicate there may be an impairment of a reporting unit, using a fair value methodology. In performing th e review of the fair value of the reporting unit, the Company considers qualitative factors as well as quantitative factors such as cash flow analysis, which projects the future cash flows and discounts those cash flows to the present value. The projection of future cash flows is dependent upon assumptions regarding future levels of income, including changes in Medicare and Medicaid reimbursement regulations. If carrying value exceeds fair value, the goodwill or indefinite-lived intangible assets are potentially impaired, subject to additional analysis. There were no impairments of goodwill or indefinite-lived intangible assets recorded in 2015. See Note 6 for a discussion of the Company’s 2014 impairment charg e for trademarks and tradenames and 2015 disposition of goodwill.

Asset Impairment s

The carrying val ue of property and equipment is reviewed quarterly to determine if facts and circumstances suggest that the assets may be impaired or that the useful life may need to be changed. The Company considers internal and external factors relating to each asset, including cash flow s, contract changes, local market developments, national health care trends, and other publicly available information. If these factors and the projected undiscounted cash flows of the business over the remaining useful life indicate that the asset will not be recoverable, the carrying value is adjusted to the estimated fair value.

Marketable Securities

The Company invests in a diversified portfolio of fixed income mutual fund s, which is classified as trading securities and is included in other long-term assets in the consolidated balance sheet s. Trading securities are recorded at fair value on the consolidated balance sheet s with any gains or losses recognized currently in earnings. The Company does not intend to engage in active trading of the securities as the assets are held in a rabbi trust that was established to approximate the Company’s liability for certain retirement benefits. The investment gains and losses are included in interest income and other on the statements of operations. There was dividend income of $2.7 million in 2015, $2.4 million in 2014, and $3.2 million in 2013. Net realized losses of $0.5 million were recognized in earnings in both 201 5 and 201 4. The net unrealized activity recognized in earnings included losses of $2.2 million in 2015, gains of $1.6 million in 2014, and losses of $4.0 million in 2013. As of December 3 1, 201 5 and 201 4, the Company d id not have any investments classified as available-for-sale or held-to-maturity.

9

Insurance Risks

The Company purchases general and professional liability insurance and maintains an unaggregated self-insured retention per occurrence ranging from $0.5 million to $12.5 million, depending on the policy year and state where the respective Company operation is located. Provisions for estimated settlements, including incurred but not reported claims, have been provided on an undiscounted basis in the peri od to which the coverage relates based on internal and external evaluations of the merits of the individual claims and an analysis of claim history. Management reviews the total liability b ased on the Company’s historical data and review of recent claims, cost and other trends, and records a ny resulting adjustments in current results of operations. Claims are paid over varying periods, which generally range from one to eight years after occurrence. See Note 10 for further discussion.

The Company’s workers’ compensation insurance consists of a combination of insured and self-insured programs and limited participation in certain state programs. Under insured programs, t he Company is responsible for up to $0.5 million per occurrence. For self-insured programs, t he Company is responsible for up to $1.0 million per occurrence and maintains insurance above this amount. The Company records an estimated liability, including incurred but not reported claims, for all losses attributable to workers’ compensation claims based on internal evaluations and an analysis of claim history based on loss claim data, trends, and assumptions. Claims are paid over varying periods and are generally fully paid within eight years. The workers’ compensation liability had a short-term component of $22.2 million and $22.3 million at December 3 1, 201 5 and 201 4, respectively, which w as included in accrued insurance liabilities, and long-term component of $41.8 million and $43.4 million at December 3 1, 201 5 and 201 4, respectively, which w as included in other long-term liabilities. The expense for workers’ compensation was $26.4 million for 2015, $25.2 million for 2014, and $28.1 million for 2013, which was included in operating expenses.

The C ompany also provides self-insured medical healthcare benefits to the majority of its employees and is fully responsible for all aspects of these plans. The liabilities for self-insured general and professional claims, workers compensation claims, and healthcare benefits are estimated utilizing assumptions about damage awards with regard to unpaid claims.

Concentrations of Credit Risk

Financial instruments that potentially subject the Company to significant concentrations of credit risk consist of cash and cash equivalents and restricted cash and cash equivalents, which the Company maintains with various financial institutions. The Company’s credit agreement places limitations on the types of investments that can be held. The majority of the Company’s cash equivalents are invested in money market funds. As part of its cash and risk management process, the Company performs periodic evaluations of the relative credit standing of the financial institutions. The Company has not sustained credit losses from instruments held at financial institutions.

Advertising Expense

The cost of advertising is expensed as incurred. The Company recorded advertising expense of $13.9 million in 2015, $13.7 million in 2014, and $13.5 million in 2013.

Stock-Based Compensation

C ompensation costs subject to graded vesting based on a service condition are amortized to expense on a straight-line basis over the service period for each separate ly vesting portion of the award.

10

Income Taxes

The Company accounts for income taxes and related accounts under the liability method. Deferred tax assets and liabilities are determined based on the difference between the financial statement and tax bases of assets and liabilities using enacted rates expected to be in effect during the year in which the basis differences reverse. In December 2015, the Company early-adopted amendments to accounting standards that require a ll deferred taxes to be classified as nonc urrent. The classification changes have been applied retrospe ctively to all periods presented, resulting in a reclassification of $16.5 million from current to non-current assets on the December 31, 2014 consolidated balance sheet. A valuation allowance is provided when the Company determines that it is more likely than not that a portion of the deferred tax balance will not be realized. See Note 7 for a discussion of the Company’s valuation allowance.

The Company records a liability for unrecognized tax benefits when a n uncertain tax position does not meet the more-likely-than-not recognition threshold. This amount is analyzed on a quarterly basis and adjusted based upon changes in facts and circumstances. The Company’s effective tax rate includes recognition and adjustments to this amount. The Company records interest and penalties related to income taxes as income taxes in the statement s of operations.

Subsequent Events

The Company has evaluated subsequent events through Jan u ary 29, 201 6, the date on which the f inancial statements were available to be issued.

New Accounting Standards (not Effective)

In April 2015, amendments to accounting standards were issued that simplify the presentation of debt issuance costs. The amendments are effective for fiscal years beginning after December 15, 2015 for public companies. Early adoption is permitted. Adopting the amendments is not expected to have a material effect on the Company’s financial position or results of operations.

In February 2015, amendments to accounting standards were issued that change the consolidation analysis for limited partnerships and similar entities and added additional considerations related to the consolidation of v ariable i nterest e ntities. The amendments are effective for fiscal years, and interim periods within those years, beginning after December 15, 2015 for public companies. Early adoption is permitted. Adopting the amendments is not expected to have a material impact on the Company’s consolidated financial position or results of operations.

In August 2014, amendments to accounting standards were issued, which require management to perform interim and annual assessments of an entity’s ability to continue as a going concern within one year of the date the financial statements are issued. Additional disclosures are also required if an entity’s conditions or events raise substantial doubt about the entity’s ability to continue as a going concern. The amendments are effective for fiscal years, and interim periods within those years, beginning after December 15, 201 6 for public companies. Early adoption is permitted. Adopting the amendments is not expected to have a material effect on the Company’s financial position or results of operations.

In May 2014, amendments to the accounting standards regarding revenue from contracts with customers were issued that supersede most current revenue recognition guidance, including industry-specific guidance. The new amendments may require additional disclosures. The amendments are effective for fiscal years, and interim periods within those years, beginning after December 15, 201 7 for public companies. Early adoption is

11

permitted only for reporting periods beginning after December 15, 2016. The Company is evaluating the impact of these amendments on existing revenue recognition policies and disclosures.

3. Significant Transactions

On January 1, 2015, the Company adopted amendments to accounting standards that changed the requirements for reporting discontinued operations. As of December 31, 2014, the Company had two long-term care facilities classified as held for sale included in discontinued operations, which were sold in 2015. The two facilities were included in a master lease covering the majority of the Company’s long-term care facilities. In 2015, the Company agreed to an amendment to the lease that reduced annual rent payments and extended the lease term as further described in Note 8. The amendment also included an agreement to sell 48 additional non-strategic long-term care facilities covered by the lease, 20 of which were subsequently sold in 2015. The 28 remaining facilities have been classified as held for sale and stated at the lower of book value or fair value less costs to sell. In accordance with the updated accounting standards, the results of operations of these 48 facilities were reported as continuing operations because their disposal was not expected to have a major effect on the Company’s financial results. The pre-tax loss included in continuing operations related to facilities sold or held for sale was $88.9 million in 2015, $39.2 million in 2014, and $33.8 million in 2013. The pre-tax loss in 2015 included a net loss on sale of assets of $46.7 million. The remaining sales are expected to be completed in 2016.

Assets held for sale were as follows as of December 31:

|  | 2015 |  | 2014
|  | (In thousands)
Net property and equipment |  | $ | 127,314 |  | $ | 9,217
Goodwill |  |  | 53,193 |  |  | -
Intangible assets |  |  | 2,578 |  |  | 284
|  |  | 183,085 |  |  | 9,501
Allowance for losses |  |  | (48,338) |  |  | -
Assets held for sale, less allowance for losses |  | $ | 134,747 |  | $ | 9,501

In conjunction with the master lease amendment, the Company also agreed to sell nine of its long-term care facilities to the lessor and add those properties to the master lease. Due to the Company’s continuing involvement with these properties as the ongoing tenant, the transactions are treated as financing arrangements with no gain or loss recognition at the date of sale. During 2015, seven of the facilities were transferred to the lessor and the remaining two are expected to be transferred in 2016.

4. Revenues

The Company rec e ives payment through reimbursement from: Medicare and Medicaid programs, self-pay patients, and other third party payors. Revenues under Medicare and Medicaid programs totaled $2.8 billion for 2015, $2.9 billion for 2014, and $2.9 billion for 2013. See Note 16 for revenues by reportable operating segment.

12

5. Property and Equipment

At December 3 1, p roperty and equipment held and used consist ed of the following:

|  | 2015 |  | 2014 |
|  | (In thousands) |
Property and equipment - owned |  |  |  |  |  |  |
Land and improvements |  | $ | 6,554 |  | $ | 29,738 |
Buildings and improvements |  |  | 44,138 |  |  | 105,297 |
Equipment and furnishings |  |  | 28,992 |  |  | 45,981 |
Construction in progress |  |  | 5,820 |  |  | 10,883 |
|  |  | 85,504 |  |  | 191,899 |
Less accumulated depreciation |  |  | 24,611 |  |  | 45,334 |
|  |  | 60,893 |  |  | 146,565 |
Property and equipment related to |  |  |  |  |  |  |
financing obligation and capital leases |  |  |  |  |  |  |
Land and improvements |  |  | 442,565 |  |  | 455,450 |
Buildings and improvements |  |  | 2,443,628 |  |  | 2,624,088 |
Leasehold improvements |  |  | 161,952 |  |  | 164,457 |
Equipment and furnishings |  |  | 182,733 |  |  | 190,772 |
Construction in progress |  |  | 13,201 |  |  | 20,952 |
|  |  | 3,244,079 |  |  | 3,455,719 |
Less accumulated depreciation |  |  | 676,438 |  |  | 667,843 |
|  |  | 2,567,641 |  |  | 2,787,876 |
Net property and equipment |  | $ | 2,628,534 |  | $ | 2,934,441 |

Depreciation expense, including depreciation of assets subject to capital lease and financing obligation s, amounted to $136.3 million for 2015, $141.8 million for 2014, and $14 1.5 million for 2013.

6. Assets Measured at Fair Value

Fair value is a market-based measurement determined based on the assumptions that market participants would use in pricing the asset or liability. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the asset or liability.

The following three-tier hierarchy prioritizes the inputs used in measuring fair value:

Level 1: Observable inputs such as quoted prices in active markets;

Level 2: Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and

Level 3: Unobservable inputs for which there is little or no market data, which requires the Company to develop assumptions.

13

Recurring Measurements

The fair value of the Company’s financial assets measured on a recurring basis determined using Level 1 inputs at December 31 was as follows:

|  | 2015 |  | 2014 |
|  | (In thousands) |
Assets: |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 124,982 |  | $ | 127,850 |
Current restricted cash and cash equivalents |  |  | 18,697 |  |  | 12,613 |
Non-current restricted cash |  |  | 4,118 |  |  | 6,657 |
Trading securities |  |  | 47,420 |  |  | 45,030 |
Total assets |  | $ | 195,217 |  | $ | 192,150 |

The Company’s trading securities, invested in a diversified portfolio of fixed income mutual funds, are liquid and actively traded on the exchanges, and are included in other long-term assets in the consolidated balance sheets. The funds principally invest in highly-rated, investment-grade corporate fixed income securities. There were no transfers between Level 1 and Level 2 during 201 5 or 201 4. There were no assets or liabilities classified using Level 2 or Level 3 inputs during 201 5 or 201 4.

Non-recurring Measurements

The fair value of the Company’s goodwill and indefinite-lived intangible assets measured on a non-recurring basis determined using Level 3 inputs at December 31 was as follows:

|  | Long-Term Care |  | Hospice and Home Health |
|  | 2015 |  | 2014 |  | 2015 |  | 2014 |
|  | (In thousands) |
Goodwill |  | $ | 1,941,419 |  | $ | 2,073,878 |  | $ | 662,641 |  | $ | 662,641 |
Owned trademarks and tradenames (non-amortizing) |  | $ | 187,692 |  | $ | 187,692 |  | $ | 87,000 |  | $ | 87,000 |
Certificates of need (non-amortizing) |  |  | 26,231 |  |  | 28,555 |  |  | - |  |  | - |
Intangible assets |  | $ | 213,923 |  | $ | 216,247 |  | $ | 87,000 |  | $ | 87,000 |

The fair values of the indefinite-lived intangible assets are derived from current publicly available market data and projections for each reporting unit developed using management’s best estimate of economic and market conditions over the projected future period. Based on this analysis, as of October 1, 2014 assessment date, the carrying value of the historical long-term care trademarks and tradenames was determined to be in excess of its fair value. The Company recorded a pre-tax impairment charge related to trademarks and tradenames of $203.1 million ($12 3.4 million net of taxes) in 2014.

In 2015, goodwill of $132.5 million related to the long-term care reporting unit was allocated to disposal groups that were sold or classified as held for sale. The allocation methodology was based on a relative fair value approach considering the value of the businesses to be disposed in relation to the value of the retained business. Following the allocation, the goodwill of the remaining long-term care reporting unit was tested for impairment. Based on the impairment testing methodology described in Note 2, no goodwill impairment charges were recorded in 201 5 or 201 4. Accumulated goodwill impairment charges were $772.2 million at both December 31, 201 5 and 201 4.

14

7. Income Taxes

The provision f or income taxes from continuing operations consisted of the following:

|  | Year ended December 31, |
|  | 2015 |  | 2014 |  | 2013 |
|  | (In thousands) |
Current: |  |  |  |  |  |  |  |  |  |
Federal |  | $ | - |  | $ | (2,245) |  | $ | (7,182) |
State and local |  |  | 162 |  |  | (121) |  |  | (613) |
|  |  | 162 |  |  | (2,366) |  |  | (7,795) |
Deferred: |  |  |  |  |  |  |  |  |  |
Federal |  |  | 6,246 |  |  | 175,478 |  |  | 359,492 |
State and local |  |  | (1,598) |  |  | 36,569 |  |  | 70,829 |
|  |  | 4,648 |  |  | 212,047 |  |  | 430,321 |
Interest and penalties expense (income) |  |  | 776 |  |  | 723 |  |  | (421) |
Provision for income taxes |  | $ | 5,586 |  | $ | 210,404 |  | $ | 422,105 |

The reconciliation of the amount computed by applying the statutory federal income tax rate to loss f rom continuing operations befo re income taxes to the provision for income taxes was as follows:

|  | Year ended December 31, |
|  | 2015 |  | 2014 |  | 2013 |
|  | (In thousands) |
Income tax (benefit) expense computed at statutory rate |  | $ | (34,901) |  | $ | (61,083) |  | $ | 25,514 |
Differences resulting from: |  |  |  |  |  |  |  |  |  |
State and local income taxes, net of federal effect |  |  | (933) |  |  | 23,691 |  |  | 45,640 |
Goodwill disposition |  |  | 42,693 |  |  | - |  |  | - |
Employment tax credits |  |  | (2,600) |  |  | (2,925) |  |  | (4,571) |
Other |  |  | 1,327 |  |  | 2,061 |  |  | 175 |
Valuation allowance |  |  | - |  |  | 248,660 |  |  | 355,347 |
Provision for income taxes |  | $ | 5,586 |  | $ | 210,404 |  | $ | 422,105 |

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amount used for income tax purposes.

15

Significant components of the Company's federal and state deferred tax assets and liabilities were as follows at December 31:

|  | 2015 |  | 2014 |
|  | (In thousands) |
Deferred tax assets: |  |  |  |  |  |  |
Financing obligation |  | $ | 2,170,972 |  | $ | 2,237,288 |
Goodwill |  |  | 343,929 |  |  | 377,053 |
Accrued insurance liabilities |  |  | 137,480 |  |  | 127,148 |
Employee compensation and benefits |  |  | 54,453 |  |  | 48,502 |
Other |  |  | 11,656 |  |  | 9,374 |
Net operating loss and credit carryforward |  |  | 56,778 |  |  | 27,481 |
|  |  | 2,775,268 |  |  | 2,826,846 |
Valuation allowance |  |  | (681,433) |  |  | (681,916) |
|  |  | 2,093,835 |  |  | 2,144,930 |
Deferred tax liabilities: |  |  |  |  |  |  |
Depreciable/amortizable assets |  |  | 1,103,382 |  |  | 1,149,199 |
Tax accounting method change |  |  | 5,439 |  |  | 8,152 |
Other |  |  | 2,472 |  |  | 2,355 |
|  |  | 1,111,293 |  |  | 1,159,706 |
Net deferred tax assets |  | $ | 982,542 |  | $ | 985,224 |

Deferred tax assets are recorded to the extent the assets will more likely than not be realized. In making such determination, management considered all available positive and negative evidence, including reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies, and recent financial performance. The projection of future taxable income requires management’s judgment in assessing industry trends and future profitability. Based on the evaluation, the valuation allowance was increased as of December 31, 2014 to measure only the portion of the deferred tax assets that is more likely than not to be realized. The allowance was not changed in 2015. The portion of the deferred tax assets considered realizable could be adjusted in the future if positive or negative developments cause a change in the amount of, or weight given to, management’s projections of future income.

The valuation allowance includes $48.0 million and $22.7 million in 2015 and 2014, respectively, related to Feder al net operating loss carryforwards of $85.8 million expiring in 2 034 or later and Federal tax credit carryforwards of $18.0 million expiring in 2032 or later. The valuation allowance also includes $13.1 million and $7.1 million in 2015 and 2014, respectively, related to the Company’s state and local tax loss and credit carryforwards with expi rations between 2015 and 2035.

The activity in the valuation allowance for deferred tax assets was as follows:

|  | 2015 |  | 2014 |  | 2013 |
|  | (In thousands) |
Balance at January 1 |  | $ | 681,916 |  | $ | 400,678 |  | $ | 538 |
Charged to costs and expenses |  |  | - |  |  | 280,597 |  |  | 399,547 |
Other |  |  | (483) |  |  | 641 |  |  | 593 |
Balance at December 31 |  | $ | 681,433 |  | $ | 681,916 |  | $ | 400,678 |

16

A reconciliation of the beginning and ending amount of unrecognized tax benefits was as follows:

|  | 2015 |  | 2014 |  | 2013 |
|  | (In thousands) |
Balance at January 1 |  | $ | 15,691 |  | $ | 16,505 |  | $ | 18,296 |
Increases related to current-year tax positions |  |  | 794 |  |  | 733 |  |  | 719 |
Increases related to prior-year tax positions |  |  | 15 |  |  | 11 |  |  | 6 |
Decreases related to prior-year tax positions |  |  | (557) |  |  | (958) |  |  | (1,107) |
Settlements |  |  | - |  |  | (102) |  |  | (1,002) |
Lapse of statute |  |  | (445) |  |  | (498) |  |  | (407) |
Balance at December 31 |  | $ | 15,498 |  | $ | 15,691 |  | $ | 16,505 |
Unrecognized tax benefits, which if recognized, would impact the Company's effective income tax rate |  | $ | 10,678 |  | $ | 10,794 |  | $ | 11,192 |
Accrued interest and penalties at December 31 |  | $ | 4,406 |  | $ | 3,604 |  | $ | 3,121 |

The Company or one or more of its subsidiaries files income tax returns in the U.S. federal jurisdiction and most states. With few exceptions, the Company is no longer subject to U.S. federal, state, or local income tax examinations for years before 2011. Within the next twelve months, it is reasonably possible that the balance of unrecognized tax benefits related to prior-year positions could decrease by approximately $3.5 million.

Income taxes paid or refunds received, including related interest, amounted to net refunds of $10.8 million in 2015, net refunds of $10.4 million in 2014, and net payments of $0.9 million in 2013.

8. Debt and Financing Obligation

At December 3 1, debt and financing obligation consisted of the following:

|  | 2015 |  | 2014 |
|  | (In thousands) |
Revolving credit facility |  | $ | - |  | $ | - |
Term loan |  |  | 381,000 |  |  | 385,000 |
Financing obligation |  |  | 5,435,564 |  |  | 5,703,003 |
Notes |  |  | 106 |  |  | 106 |
Capital lease obligations |  |  | 19,699 |  |  | 20,206 |
|  |  | 5,836,369 |  |  | 6,108,315 |
Less amounts due within one year |  |  | 130,721 |  |  | 180,093 |
Long-term debt and financing obligation |  | $ | 5,705,648 |  | $ | 5,928,222 |

Revolving Credit Facility and Term Loan

T he Company has a credit agreement with a group of lenders that provides for a $175 million revolving credit facility and a $400 million term loan. Subject to covenant compliance, certain conditions and other limitations, borrowings under the credit agreement could be increased by up to the greater of (i) $250 million as additional, but uncommitted, loans across either of the term loan or revolving credit facility plus, in either case, an amount equal to optional prepayments of the term loan made prior to the date of increase, and (ii) the amount of additional indebtedness permitted under the applicable leverage ratio set forth in the credit agreement, less 25

17

basis points. In 2015, a majority of the le nders in the group agreed to extend the ir portion of the revolving credit facility for two additional years beyond the original termination date of April 6, 2016. For the two-year extension period, the revolving credit facility will have a borrowing capacity of no less than $120 million. Both t he extended revolving credit facility and t he term loan will mature on April 6, 2018. The term loan requires repayment of principal in equal consecutive quarterly installments of $1.0 million with the remaining balance being due at maturity. In addition, there are certain mandatory prepayments based on incurrence of debt, asset sales or recovery events, and excess cash flow, as defined in the credit agreement.

The obligations under the credit agreement are guaranteed by all of the Company’s existing and subsequently acquired direct and indirect, wholly owned, domestic subsidiaries and are secured by a first lien on substantially all of the Company’s assets. The credit agreement contains various covenants, restrictions, and events of default. Among other things, these provisions require the Company to maintain certain financial ratios and impose certain limits on its ability to merge and consolidate with other companies, incur indebtedness, grant liens or security interests on assets, make acquisitions, loans, advances or investments, pay dividends, sell or otherwise transfer assets, optionally prepay or modify terms of any junior indebtedness, or enter into transactions with affiliates.

The interest rate on borrowings under the term loan is, at the Company’s option, a base rate (subject to a floor of 2.50%) plus a margin of 2.50%, or a Eurodollar rate (subject to a floor of 1.50%) plus a margin of 3.50%. The interest rate on borrowings under the revolving credit facility is, at the Company’s option, a base rate plus a margin or a Eurodollar rate plus a margin. The applicable margin for the revolving facility is based on the Company’s total senior leverage ratio, ranging from 2.00% to 2.50% for base rate loans and 3.00% to 3.50% for Eurodollar loans. The revolving credit facility also requires a commitment fee ranging from 0.375% to 0.5%, depending on the same senior leverage ratio. In addition to direct borrowings, the revolving credit facility may be used to support the issuance of letters of credit. As of December 3 1, 201 5, there were no loans outstanding under this facility. After consideration of usage for letters of credit, $108.2 million was available for future borrowing. The interest rate on the term loan was 5.0% at both December 3 1, 201 5 and 201 4.

Financing Obligation

The Company guarantees lease obligations under a master lease agreement covering a majority of the Company’s long-term care facilities. See Note 3 for a discussion of 2015 amendments to the master lease. The guaranty imposes certain limits on the Company’s ability to pay dividends, incur indebtedness, and complete material acquisitions unless a specified coverage ratio is maintained. Based on its coverage ratio, as defined in the guaranty, the Company has been restricted from making any dividend payments to common shareholders.

The master lease properties are grouped into four lease pools with initial terms that expire in 2029, 2030, 2032, and 2033. At the Company’s option, assuming no events of default, the master lease may be extended with respect to any pool of properties. The renewal periods extend the term of the master lease with respect to the relevant pool of properties from between six and 22 years. If the Company elects to renew the term of the master lease with respect to any pool, the renewal is effective as to all of the properties in that pool. The Company does not have the right to terminate its obligations under the master lease and the master lease provides purchase options only in limited circumstances such as casualty.

The Company is responsible for paying taxes, utility charges, and insurance premiums related to the master lease properties. The lease provides for annual rent increases of 3.0% through the expiration of the initial term. In the first year of any extension term, the rent will reset to an amount equal to the greater of (i) the then fair market rental for the properties or (ii) the rent for the previous year increased by 3.0%, and will increase in each

18

subsequent lease year by a percentage equal to the greater of (i) 3.0% or (ii) the Consumer Price Index increase. The Company is responsible for maintaining the properties in good order and repair and for expending an annual minimum amount for capital projects, which includes a per bed minimum to be expended at each facility.

The master lease defines certain events as events of default. An event of default under the master lease would also result in a cross-default under the revolving credit facility, which could result in the acceleration of the Company’s obligations and termination of lending commitments thereunder. Upon an event of default, there are certain remedies available to the lessor, as further set forth in the master lease. Under certain circumstances, the lessor could require the Com pany to purchase the property. There were no events of default as of December 31, 2015.

As described in Note 3, the Company entered into an amendment to the master lease effective April 1, 2015 which reduced the monthly rent payments and reset rent escalations to 3.0% for each lease year through the expiration of the initial term. The initial lease term was also extended five years while keeping the same extension options. As the divestitures described in Note 3 are completed, an amount equal to the net proceeds is paid to the lessor, reducing the financing obligation. Subsequent annual rent is reduced by 7.75% of net sale proceeds and future amortization of financing obligation principal is adjusted to reflect future cash flows.

The lease amendment also includes deferred rent obligations to the lessor totaling $525.0 million, in two tranches: (i) a t ranche A deferred rent obligation of $275.0 million and (ii) a t ranche B deferred rent obligation of $250.0 million. Until the t ranche A obligation is paid, the Company will make additional payments to the lessor equal to 6.9% of the outstanding t ranche A amount. The lease amendment included an agreement by the Company to sell and leaseback nine long-term care facilities for an aggregate purchase price of $275.0 million and to use the proceeds to reduce the t ranche A deferred rent obligation.

Until paid, the t ranche B deferred rent obligation increases annually by (i) 3.0% in 2016 through 2018, (ii) 4.0% in 2019, (iii) 5.0% in, 2020, and (iv) 6.0% in 2021 and thereafter. The d eferred r ent o bligation s are due and payable on the earlier of (i) certain capital or liquidity events of the Company, or (ii) March 31, 2029. Payments expected to be made in cash related to the deferred rent obligations have been included in the Company’s future minimum lease payment schedule shown in Note 9.

Fair Value

At December 3 1, 20 1 5 and 20 1 4, the carrying value of the Company’s debt, excluding capital lease and financing obligations, was $381.1 million and $385.1 million, and the fair value was $366.6 million and $364.9 million, respectively. The fair value of the Company’s variable-rate term loan was calculated based on a quoted market price, and wa s classified as Level 1 in the fair value hierarchy, as described in Note 6.

Other Information

Interest paid, primarily related to debt and the financing obligation, amounted to $455.9 million in 2015, $405.9 million in 2014, and $415.2 million in 2013.

Debt maturities, excluding capital lease and financing obligation s, subsequent to December 3 1, 201 5 are as follows: 201 6 – $4.1 million; 2 01 7 – $4.0 million; and 2 01 8 – $373.0 million.

19

9. Leases and Commitments

Leases

The Company leases certain property and equipment under both operating and capital leases, which expire at various dates t hrough 2036. Certain of the leases contain purchase options. The Company also has a financing obligation related to a master lease.

Payments under non-cancelable operating leases, the present value of net minimum lease payments under capital lease s, and minimum lease payments under financing obligation s as of December 3 1, 20 1 5 are as follows:

|  | Operating Leases |  | Capital Lease Obligations |  | Financing Obligation |
|  | (In thousands) |
2016 |  | $ | 8,230 |  | $ | 2,124 |  | $ | 466,085 |
2017 |  |  | 5,946 |  |  | 2,139 |  |  | 480,067 |
2018 |  |  | 4,107 |  |  | 2,149 |  |  | 494,469 |
2019 |  |  | 2,365 |  |  | 2,166 |  |  | 509,303 |
2020 |  |  | 1,181 |  |  | 2,084 |  |  | 524,582 |
Later years |  |  | 5,051 |  |  | 25,407 |  |  | 6,934,700 |
Total minimum lease payments |  | $ | 26,880 |  |  | 36,069 |  |  | 9,409,206 |
Plus residual financing obligation |  |  |  |  |  | - |  |  | 1,470,663 |
Less amount representing interest |  |  |  |  |  | 16,370 |  |  | 5,444,305 |
Present value of net minimum lease payments (included in debt and financing obligation - see Note 8) |  |  |  |  | $ | 19,699 |  | $ | 5,435,564 |

T he residual financing obligation approximate s the expected net book value of the related assets at the end of the lease to avoid a built-in loss. Rental expense was $13.8 million for 2015, $13.6 million for 2014, and $1 3.6 million for 2013.

Contractual Commitments

As of December 31, 201 5, the Company had contractual commitments of $5.2 million relating to its internal construction program. As of December 31, 201 5, the Company had total letters of credit of $66.8 million that benefit certain third-party insurers, and 90% of these letters of credit related to recorded liabilities.

10. Contingencies (including amounts related to discontinued operations)

The Company is party to legal matters arising in the ordinary course of business, including patient care-related claims and litigation, employment-related claims, regulatory matters, and environmental actions. Management continually evaluates all contingencies based on the best available evidence, and believes that liabilities have been recorded for all losses that are both probable and can be reasonably estimated. These estimates involve significant judgment and accordingly, the Company’s estimate of losses may change from time to time and actual losses may be more or less than the current estimate. No estimate of loss or range of possible losses in excess of amounts accrued can be established at this time, individually or in the aggregate, for the matters described below.

20

General and Professional Self-Insured Liabilities and Litigation

The Company and others in the healthcare industry are subject to claims and lawsuits related to patient care and treatment. The Company’s allowance for professional liability risks, as described in Note 2, includes an estimate of the expected cost to settle reported claims and an amount, based upon past experience, for losses incurred but not yet reported. G eneral and professional liability had a short-term component of $92.8 million and $92.0 million at December 31, 201 5 and 201 4, respectively, which w as included in accrued insurance liabilities, and long-term component of $222.4 million and $197.0 million, respectively, which w as included in other long-term liabilities. The expense for general and professional liability claims, premiums and administrative fees of $120.6 million for 2015, $120.6 million for 2014, and $95.3 million for 2013, was included in operating expenses of continuing and discontinued operations. These liabilities are necessarily based on estimates and a lthough management believes that the liability is adequate, the ultimate liability may be in excess of, or less than, the amounts recorded which could result in an adjustment to future earnings.

Regulatory Matters

The Company is routinely and currently subject to various payment reviews, audits and inquiries as a result of participating in the Medicare and Medicaid programs and currently and routinely responds to governmental demands, subpoenas, and other requests for information regarding the business and operations of the Company’s business units. Management has responded to a Civil Investigative Demand, subpoenas, and other requests for information about the Company’s skilled nursing facilities in connection with an inquiry coordinated by the U.S. Department of Justice, the Department of Health and Human Services, Office of Inspector General, and certain state attorneys general offices. In 2015, three qui tam lawsuits previously filed in the Eastern District of Virginia under the False Claims Act and certain state laws were unsealed, and a Complaint in Intervention filed by t he United States was unsealed. T he Complaint asserts claims against the Company under the False Claims Act based on allegations that the Company billed federal healthcare programs for services that were not reasonable and necessary, and/or were not skilled in nature. The Company believes it is in material compliance with all applicable laws and regulations and is vigorously defending itself in this matter. However, because the matter is ongoing, the ultimate outcome is uncertain and could, among other things, (1) require substantial management time and costs to continue to defend the Company’s actions; (2) require the Company to refund or adjust amounts previously paid for services under the governmental programs; (3) require payment of substantial fines, penalties or other sanctions; (4) result in the loss of the Company’s facilities’ right to participate in the Medicare or Medicaid programs; or (5) cause damage to the Company’s reputation.

Employment-Related Lawsuits

A variety of federal and state employment-related laws and regulations apply to the Company’s operations including the U.S. Fair Labor Standards Act, regulations of the Equal Employment Opportunity Commission, regulations of the Office of Civil Rights, federal and state wage and hour laws, state minimum staffing requirements applicable to healthcare providers, and a variety of other laws enacted to govern employment-related matters. The Company has employment-related claims at various stages of investigation and resolution. Liabilities are recorded for such claims when losses are probable and the amount can be reasonably estimated.

Environmental Liabilities

One or more subsidiaries or affiliates of the Company have been identified as potentially responsible parties (PRPs) in a variety of actions (the Actions) relating to waste disposal sites which allegedly are subject to remedial action under the Comprehensive Environmental Response Compensation Liability Act, as amended, 42 U.S.C. Sections 9601 et seq. (CERCLA) and similar state laws. CERCLA imposes retroactive, strict joint and several liability on PRPs for the costs of hazardous waste clean-up. The Actions allege that PRPs

21

transported and/or generated hazardous substances that came to be located at the sites in question. The potential liability exposure for currently pending environmental claims and litigation, without regard to insurance coverage, cannot be quantified with precision because of the inherent uncertainties of litigation in the Actions and the fact that the ultimate cost of the remedial actions for some of the waste disposal sites where subsidiaries or affiliates of the Company are alleged to be a PRP has not yet been quantified. At December 3 1, 201 5 and 20 1 4, the Company had $2.6 million accrued at each date in other long-term liabilities based on its current assessment of the likely outcome of the Actions. The a mount of the Company’s liability wa s determined based on management’s continual monitoring of the litigation activity, estimated clean-up costs, and the portion of the liability for which the Compan y is responsible.

1 1. Discontinued Operations

The Company continually evaluates the performance of its operating units to determine whether to close or sell underperforming or non-strategic assets. During 2015, the Company completed the sales of two long-term care facilities and one home care agency that were held for sale and classified as discontinued operations as of December 31, 2014. During 2014, the operations of two long-term care facilities were sold. The Company sold one long-term care facility in 2 013. The results of operations and the gain on sale, if applicable, for these operating units were presented as discontinued operations for all periods. See Note 3, regarding the 2015 divestiture plan which is accounted for as part of continuing operations under the new account ing standards effective January 1, 2015.

Following is a summary of discontinued operations:

|  | Year ended December 31, |
|  | 2015 |  | 2014 |  | 2013 |
|  | (In thousands) |
Revenues |  | $ | 4,499 |  | $ | 32,685 |  | $ | 58,243 |
Loss from operations before income tax benefit |  | $ | (15,736) |  | $ | (24,397) |  | $ | (27,439) |
Income tax benefit |  |  | (6,216) |  |  | (9,550) |  |  | (10,835) |
Loss from operations |  |  | (9,520) |  |  | (14,847) |  |  | (16,604) |
Gain on divestiture of operations, net of income taxes of $2,599, $3,786 and $4,597 |  |  | 3,980 |  |  | 5,846 |  |  | 7,120 |
Loss from discontinued operations |  | $ | (5,540) |  | $ | (9,001) |  | $ | (9,484) |

The Company retains risk for loss contingencies related to discontinued operations as described in Note 10. Such liabilities we re estimated based o n the best available evidence and are updated as additional information becomes available. Any changes to estimates are recorded in results of discontinued operations.

1 2. Redeemable Preferred Stock and Common Stock

Redeemable Preferred Stock

The preferred stock has a liquidation preference of $1,000 per share, plus any unpaid accrued dividends. The preferred holders receive dividends equal to 10% of the liquidation preference, payable semiannually on October 1 and April 1. The preferred holders are only entitled to the limited voting rights granted under Delaware law and the preferred stock is not convertible into any other stock of the Company. T he Company has the right to redeem the outstanding preferred stock, in whole but not in part, in an aggregate amount equal

22

to the liquidation preference of all such stock, plus any unpaid accrued dividends, to the date of redemption on the date of the earliest to occur of (i) April 7, 2016, (ii) the initial public offering of equity interests of the Company or its successor entity, or (iii) a sale of the Company. As of April 7, 2016, holders of a majority of the outstanding preferred stock will have the right to cause the Company to redeem the preferred stock, in whole but not in part, in an aggregate amount equal to the liquidation preference of all such shares, plus any unpaid accrued dividends. Any preferred stock redeemed by the Company will be cancelled.

The redeemable preferred stock is classified outside of permanent equity because it is redeemable at the option of the holders. The carrying value of the preferred stock was equal to the redemption value of $1,025 per share at both December 31, 201 5 and 201 4.

Common Stock

Pursuant to a shareholders agreement, there are restrictions on the ability to transfer or sell shares. Certain executive officers have a right to require the Company to repurchase their equity securities if their employment is terminated without cause or by reason of death or disability.

1 3. S tock-Based Compensation

The Company maintains an Equity Incentive Plan under which it has granted awards to executive and non-executive officers. At December 31, 201 5, there were 144,953 shares available for grant under the plan.

Restricted Stock

Restricted stock balances include both fully vested and non-vested restricted stock. Certain restricted shares will vest immediately upon the Company’s principal shareholders liquidating down to less than 30% of their holdings on the grant date, and other shares also require achieving certain rates of return in connection with the liquidity event. Any outstanding restricted shares that have not vest ed upon the occurrence of a liquidity event will become time-vested restricted shares that vest two years after the principal shareholders liquidate down to less than 10% of their holdings on the grant date. The grant-date fair value of non-vested restricted shares will be determined and expensed at such time a liquidity event becomes probable. The non-vested restricted shares have the right to receive forfeitable dividends.

The restricted stock activity for 201 5 was as follows:

|  | Shares |
Non-vested restricted shares: |  |  |
Outstanding at December 31, 2014 |  | 1,997,603 |
Granted |  | 1,640,000 |
Forfeited |  | (30,817) |
Outstanding at December 31, 2015 |  | 3,606,786 |

In June 2014, all holders of outstanding stock options elected to participate in the Company’s offer to exchange options for liquidity-vested restricted common stock of the Company on a four options for one restricted share basis. The Company’s stock-based compensation expense was $0 for 2015, $0.1 million for 2014, and $0.6 million for 2013, which includes time-vested stock options and restricted stock, if applicable. Stock-based compensation expense was recorded in general and administrative expenses.

23

1 4. Employee Benefit Plans

Defined Benefit Plans

The Company ha s one qualified and two non-qualified defined benefit pension plans. The qualified plan is an underfunded plan with continuing benefits. The unfunded non-qualified plans include one plan with frozen future benefits and one with continuing benefits.

Obligations and Funded Status

The funded status of the plan was as follows:

|  | 2015 |  | 2014 |
|  | (In thousands) |
Change in projected benefit obligation |  |  |  |  |  |  |
Benefit obligation at beginning of year |  | $ | 18,232 |  | $ | 17,252 |
Service cost |  |  | 929 |  |  | 955 |
Interest cost |  |  | 646 |  |  | 828 |
Actuarial (gain) loss |  |  | (2,728) |  |  | 4,165 |
Benefits paid |  |  | (1,498) |  |  | (181) |
Settlements |  |  | (119) |  |  | (4,787) |
Benefit obligation at end of year |  |  | 15,462 |  |  | 18,232 |
Change in plan assets |  |  |  |  |  |  |
Fair value of plan assets at beginning of year |  |  | 1,521 |  |  | 1,677 |
Actual return on plan assets |  |  | 13 |  |  | 53 |
Employer contribution |  |  | 1,481 |  |  | 4,759 |
Benefits paid |  |  | (1,498) |  |  | (4,777) |
Settlements |  |  | (119) |  |  | (191) |
Fair value of plan assets at end of year |  |  | 1,398 |  |  | 1,521 |
Funded status at end of year |  | $ | (14,064) |  | $ | (16,711) |
Amounts recognized in the balance sheets consisted of: |  |  |  |  |  |  |
Current liabilities |  | $ | (42) |  | $ | (165) |
Long-term liabilities |  |  | (14,022) |  |  | (16,546) |
|  | $ | (14,064) |  | $ | (16,711) |
Amounts in accumulated other comprehensive loss that have not been recognized in net periodic pension cost, net of tax: |  |  |  |  |  |  |
Net actuarial loss |  | $ | 975 |  | $ | 2,828 |
Accumulated benefit obligation for all plans |  | $ | 9,298 |  | $ | 11,033 |

The Company expects to recognize less than $0.1 million of the net actuarial loss in 201 6.

24

Components of Net Pension Cost

|  | Year ended December 31, |
|  | 2015 |  | 2014 |  | 2013 |
|  | (In thousands) |
Service cost |  | $ | 929 |  | $ | 955 |  | $ | 879 |
Interest cost |  |  | 646 |  |  | 828 |  |  | 607 |
Expected return on plan assets |  |  | (85) |  |  | (92) |  |  | (121) |
Amortization of net actuarial loss |  |  | 235 |  |  | 146 |  |  | 99 |
Settlement loss |  |  | 27 |  |  | 1,095 |  |  | 46 |
Net pension cost |  | $ | 1,752 |  | $ | 2,932 |  | $ | 1,510 |

Disclosure Assumptions

|  | 2015 |  | 2014 |
For determining benefit obligations at December 31: |  |  |  |  |
Weighted-average discount rate |  | 4.22 | % | 3.75 | %
Rate of compensation increase |  | 5.00 | % | 5.00 | %

|  | 2015 |  | 2014 |  | 2013 |
For determining net pension cost for the year: |  |  |  |  |  |  |
Weighted-average discount rate |  | 3.75 | % | 4.73 | % | 3.71 | %
Expected return on assets |  | 6.25 | % | 6.25 | % | 7.00 | %
Rate of compensation increase |  | 5.00 | % | 5.00 | % | 5.00 | %

The rate of compensation increase applies to plans with continuing benefits. The expected long-term rate of return on plan assets is based on the historical trend for the Company’s qualified pension plan.

Plan Asset s

T he Company measures the assets held in its qualified defined benefit pension plan at fair value using the three-tier hierarchy described in Note 6. A ll of the Company’s pension assets use Level 1 observable inputs such as quoted prices in active markets.

The fair values of the Company’s defined benefit pension plan assets at December 3 1 we re as follows:

|  | 2015 |  | 2014 |
|  | (In thousands) |
Asset Category: |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 3 |  | $ | 3 |
Equity securities |  |  | 706 |  |  | 755 |
Debt securities |  |  | 689 |  |  | 763 |
Total assets |  | $ | 1,398 |  | $ | 1,521 |

The Company’s investment strategy for its defined benefit plan is a target of 5 0% equity securities and 5 0% debt securities, which is rebalanced from time to time to approximate that mix. Equity securities consist of domestic mutual funds in large, medium, and small cap companies. Debt securities consist of bond mutual fund s.

25

Cash Flows

The expected benefit payments for the 10 year s subsequent to December 3 1, 201 5 are as follows:

201 6 – $0.2 million; 201 7 – $3.5 million; 2 01 8 – $0.2 million; 201 9 – $0.1 million; 20 20 – $0.2 million; and 20 2 1-202 5 – $45.2 million. In 20 1 6, the Company expects to contribute pension payments of less than $0.1 million.

Other Information

In addition to the benefit liabilities in the tables above, the Company has a supplemental obligation to certain officers. The Company has committed to fund this obligation by releasing a portion of the Company’s interest in the cash surrender values of split-dollar life insurance arrangements to these officers upon retirement, if necessary. The Company’s share of the cash surrender value of the policies was $1.7 million and $2.7 million at December 3 1, 20 1 5 and 201 4, respectively. The balances were included in other long-term assets. T he Company’s obligation of $1.7 million and $2.1 million at December 31, 201 5 and 201 4, respectively, was included in other long-term liabilities.

Defined Contribution Plans

The Company maintains a savings program qualified under Section 401(k) of the Intern al Revenue Code and other non-qualified, deferred compensation programs. The Company’s expense for these plans was $8.7 million in 2015, $16.4 million in 2014, and $21.6 million in 2013. T he Company matches participant contribution s up to a maximum of 1% of the participant’s compensation, as defined in each plan. The match was suspended for the first half of 2015, and resumed on July 1, 2015. The fluctuations in expense from 2013 to 2014 were attributable to the obligation s of the non-qualified programs.

1 5. Accumulated Other Comprehensive (Loss) Income

The changes in accumulated other comprehensive loss, by component, were as follows:

|  | 2015 |  | 2014 |  | 2013 |
| (In thousands) |
Defined benefit pension plans, net of income taxes: |  |  |  |  |  |  |  |  |  |
Balance at January 1 |  | $ | (2,828) |  | $ | (954) |  | $ | (1,917) |
Change before reclassifications: |  |  |  |  |  |  |  |  |  |
Net actuarial gain (loss) |  |  | 2,656 |  |  | (4,204) |  |  | 1,401 |
Tax effect |  |  | (967) |  |  | 1,633 |  |  | (527) |
|  |  | 1,689 |  |  | (2,571) |  |  | 874 |
Amounts reclassified: |  |  |  |  |  |  |  |  |  |
Amortization of net actuarial loss |  |  | 235 |  |  | 146 |  |  | 99 |
Settlement loss |  |  | 27 |  |  | 1,095 |  |  | 46 |
Tax effect |  |  | (98) |  |  | (544) |  |  | (56) |
|  |  | 164 |  |  | 697 |  |  | 89 |
Other comprehensive income (loss), net |  |  | 1,853 |  |  | (1,874) |  |  | 963 |
Balance at December 31 |  | $ | (975) |  |  | (2,828) |  | $ | (954) |

26

1 6. Segment Information

The Company’s reportable operating segments are Long-T erm Care and Hospice and Home Health. Long-Term Care includes the operation of skilled nursing centers, assisted living facilities, and memory care facilities. T he Other category include s other health care-related business es. Asset information by segment, including capital expenditures, is not provided to the Company’s chief operating decision maker.

The accounting policies of the operating segments are the same as those described in the summary of signifi cant accounting policies described in Note 2. The Company evaluates performance and allocates resources based on operating margin, which represents revenues less operating expenses.

|  | Long-Term |  | Hospice and |  |  |  |  |  |  |
|  | Care |  | Home Health |  | Other |  | Total |
|  | (In thousands) |
Year ended December 31, 2015: |  |  |  |  |  |  |  |  |  |  |  |  |
Revenues from external customers |  | $ | 3,468,999 |  | $ | 532,131 |  | $ | 78,445 |  | $ | 4,079,575 |
Depreciation and amortization |  |  | 130,906 |  |  | 1,718 |  |  | 4,813 |  |  | 137,437 |
Operating margin |  |  | 560,225 |  |  | 106,856 |  |  | 1,956 |  |  | 669,037 |
Year ended December 31, 2014: |  |  |  |  |  |  |  |  |  |  |  |  |
Revenues from external customers |  | $ | 3,539,399 |  | $ | 526,308 |  | $ | 79,813 |  | $ | 4,145,520 |
Depreciation and amortization |  |  | 136,680 |  |  | 1,959 |  |  | 4,228 |  |  | 142,867 |
Operating margin |  |  | 604,734 |  |  | 112,813 |  |  | 4,543 |  |  | 722,090 |
Year ended December 31, 2013: |  |  |  |  |  |  |  |  |  |  |  |  |
Revenues from external customers |  | $ | 3,531,764 |  | $ | 503,306 |  | $ | 81,930 |  | $ | 4,117,000 |
Depreciation and amortization |  |  | 136,190 |  |  | 1,774 |  |  | 4,605 |  |  | 142,569 |
Operating margin |  |  | 666,877 |  |  | 102,941 |  |  | 4,262 |  |  | 774,080 |

The following table reconciles segment operatin g margin to consolidated (loss) income from continuing operations before income tax es:

|  | Year ended December 31, |
|  | 2015 |  | 2014 |  | 2013 |
|  | (In thousands) |
Segment operating margin |  | $ | 669,037 |  | $ | 722,090 |  | $ | 774,080 |
General and administrative |  |  | (137,992) |  |  | (149,481) |  |  | (151,238) |
Depreciation and amortization |  |  | (137,437) |  |  | (142,867) |  |  | (142,569) |
Asset impairment |  |  | - |  |  | (203,108) |  |  | - |
Total other expenses, net |  |  | (493,324) |  |  | (401,156) |  |  | (407,376) |
(Loss) income from continuing operations before income taxes |  | $ | (99,716) |  | $ | (174,522) |  | $ | 72,897 |

27